Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.440
+0.010 (0.70%)
At close: Apr 15, 2026, 4:00 PM EDT
1.450
+0.010 (0.69%)
After-hours: Apr 15, 2026, 5:32 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $54.17 million as of April 15, 2026. Its market cap has decreased by -2.09% in one year.
Market Cap
54.17M
Enterprise Value
-66.53M
1-Year Change
-2.09%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $54.17M, a decrease of -90.38%. That is a compound annual growth rate of -65.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 53.80M | -11.55% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 58.85M |
| Actuate Therapeutics | 58.80M |
| Instil Bio | 58.66M |
| MindWalk Holdings | 57.86M |
| Dogwood Therapeutics | 56.78M |
| Kezar Life Sciences | 54.18M |
| Cue Biopharma | 53.72M |
| Radiopharm Theranostics | 53.13M |